Global COVID-19 Diagnostics Market Size Report 2022-2027


The global COVID-19 diagnostics market size reached US$ 94.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 32.1 Billion by 2027.

IMARC Group, a leading market research company, has recently releases report titled “COVID-19 Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” The study provides a detailed analysis of the industry, including the global COVID-19 diagnostics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the COVID-19 diagnostics market?

The global COVID-19 diagnostics market size reached US$ 94.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 32.1 Billion by 2027.

What is COVID-19 diagnostics?

COVID-19 is a highly infectious disease generated by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat, body aches, etc. The infection is diagnosed through several clinical tests, such as reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing, etc. These tests use kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP), human saliva, nasal swabs, or blood. They are adopted by hospitals, laboratories, clinics, research institutes, and diagnostic centers.

Request for a free sample copy of this report: https://www.imarcgroup.com/covid-19-diagnostics-market/requestsample

What are the growth prospects and trends in the COVID-19 diagnostics industry?

The sudden outbreak of coronavirus disease and a significant increase in the number of COVID-19 infected patients are primarily driving the global market for COVID-19 diagnostics. The escalating number of daily cases has resulted in the extensive adoption of diagnostic tests for rapid and comprehensive testing to facilitate early treatment for the patients. Additionally, the introduction of novel antibody and serology test kits for home-testing that consume less time and can be integrated with software-based programs for accurate results is further augmenting the product demand. Numerous other factors, including the launch of favorable government policies to contain the spread of COVID-19 infection and ongoing improvements in the healthcare infrastructures, are anticipated to drive the market growth in the coming years.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Reagents and Kits
  • Instruments
  • Others

Breakup by Sample Type:

  • Nasopharyngeal Swabs
  • Oropharyngeal Swabs
  • Nasal Swabs
  • Blood
  • Others

Breakup by Test Type:

  • Molecular (RT-PCR) Testing
  • Antigen-based Testing
  • Antibody (Serology) Testing
  • Others

Breakup by Mode:

  • Point-of-Care (PoC)
  • Non-Point-of-Care (Non-PoC)

Breakup by End Use:

  • Laboratories
  • Hospitals
  • Diagnostic Centers and Clinics
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Abbott Laboratories
  • Becton Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Hoffman-La Roche Ltd. (Roche Holding AG)
  • Luminex Corporation
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Robert Bosch GmbH
  • Seegene Inc.
  • Siemens Aktiengesellschaft
  • Thermo Fisher Scientific Inc.

Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=reportid=3552flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/